Head-to-Head: which lupus drug works better?
NCT ID NCT07053137
Summary
This study looks back at medical records to compare how well two existing drugs (telitacicept and belimumab) control lupus symptoms and how safe they are. Researchers will analyze data from 180 adults with moderate-to-severe lupus who were already taking one of these medications. No participants will receive new treatments as part of this study—it only reviews past treatment results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qianfoshan Hospital
Jinan, Shandong, 250000, China
Conditions
Explore the condition pages connected to this study.